首页> 美国卫生研究院文献>Journal of Clinical Medicine >Pain Detection with Bioimpedance Methodology from 3-Dimensional Exploration of Nociception in a Postoperative Observational Trial
【2h】

Pain Detection with Bioimpedance Methodology from 3-Dimensional Exploration of Nociception in a Postoperative Observational Trial

机译:在术后观察性试验中从伤害感受的三维探究中用生物阻抗方法进行疼痛检测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although the measurement of dielectric properties of the skin is a long-known tool for assessing the changes caused by nociception, the frequency modulated response has not been considered yet. However, for a rigorous characterization of the biological tissue during noxious stimulation, the bioimpedance needs to be analyzed over time as well as over frequency. The 3-dimensional analysis of nociception, including bioimpedance, time, and frequency changes, is provided by ANSPEC-PRO device. The objective of this observational trial is the validation of the new pain monitor, named as ANSPEC-PRO. After ethics committee approval and informed consent, 26 patients were monitored during the postoperative recovery period: 13 patients with the in-house developed prototype ANSPEC-PRO and 13 with the commercial device MEDSTORM. At every 7 min, the pain intensity was measured using the index of Anspec-pro or Medstorm and the 0–10 numeric rating scale (NRS), pre-surgery for 14 min and post-anesthesia for 140 min. Non-significant differences were reported for specificity-sensitivity analysis between ANSPEC-PRO (AUC = 0.49) and MEDSTORM (AUC = 0.52) measured indexes. A statistically significant positive linear relationship was observed between Anspec-pro index and NRS (r = 0.15, < 0.01). Hence, we have obtained a validation of the prototype Anspec-pro which performs equally well as the commercial device under similar conditions.
机译:尽管皮肤的介电性质的测量是用于评估由伤害感受引起的变化的长期已知的工具,但是尚未考虑调频响应。然而,为了在有害刺激期间对生物组织进行严格的表征,需要随时间以及频率来分析生物阻抗。 ANSPEC-PRO设备提供了伤害感受的3维分析,包括生物阻抗,时间和频率变化。这项观察性试验的目的是验证名为ANSPEC-PRO的新型疼痛监测仪。在获得伦理委员会的批准和知情同意后,在术后恢复期间对26例患者进行了监测:13例采用内部开发的原型ANSPEC-PRO的患者和13例采用商业设备MEDSTORM的患者。每隔7分钟,使用Anspec-pro或Medstorm指数和0–10数字评分量表(NRS),手术前14分钟和麻醉后140分钟测量疼痛强度。据报道,ANSPEC-PRO(AUC = 0.49)和MEDSTORM(AUC = 0.52)测量指标之间的特异性-敏感性分析没有显着差异。在Anspec-pro指数和NRS之间观察到统计学上显着的正线性关系(r = 0.15,<0.01)。因此,我们获得了对Anspec-pro原型的验证,该原型在类似条件下的性能与商用设备相同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号